SERIAL CHANGES OF PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITY IN THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - COMPARISON BETWEEN THROMBOLYTIC THERAPIES WITH MUTANT TPA (LANOTEPLASE BMS-200980) AND RECOMBINANT TPA (ALTEPLASE)/

Citation
N. Ogata et al., SERIAL CHANGES OF PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITY IN THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - COMPARISON BETWEEN THROMBOLYTIC THERAPIES WITH MUTANT TPA (LANOTEPLASE BMS-200980) AND RECOMBINANT TPA (ALTEPLASE)/, Circulation, 94(8), 1996, pp. 514-514
Citations number
NO
Categorie Soggetti
Cardiac & Cardiovascular System",Hematology
Journal title
ISSN journal
00097322
Volume
94
Issue
8
Year of publication
1996
Supplement
S
Pages
514 - 514
Database
ISI
SICI code
0009-7322(1996)94:8<514:SCOPIA>2.0.ZU;2-M